(May 2, 2024, 11:47 AM EDT) -- NEW BRUNSWICK, N.J. — Johnson & Johnson (J&J) announced May 1 that it will pay nearly $6.5 billion to resolve all ovarian cancer claims through a prepackaged plan of reorganization for another subsidiary that will file for bankruptcy in Texas if the plan is accepted by asbestos talc claimants....